SCHEMBL24290490

SCHEMBL24290490

CCNc1ccc(CN2CCOCC2)cc1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.48
HRH3 Q9Y5N1 2/20 0.47
HTT P42858 3/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
NOS1 P29475 2/20 0.44
NOS3 P29474 1/20 0.44
NOS2 P35228 1/20 0.44
HPGD P15428 4/20 0.43
NPC1 O15118 2/20 0.43
TP53 P04637 2/20 0.43
TSHR P16473 2/20 0.43
RAB9A P51151 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPK1 P28482 1/20 0.43
HIF1A Q16665 1/20 0.43
EPAS1 Q99814 1/20 0.43
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 3/20 0.42
GAA P10253 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5474252 0.83 NCF1 (0.51) NCF1HRH3HTTSMN1; SMN2NOS1
SCHEMBL30059176 0.79 HRH3 (0.59) NCF1HRH3HTTSMN1; SMN2NOS1
SCHEMBL546487 0.79 HRH3 (0.59) NCF1HRH3HTTSMN1; SMN2NOS1
SCHEMBL6202441 0.78 MAPT (0.54) SMN1; SMN2RAB9AMEN1KMT2AMAPK1
SCHEMBL4779922 0.78 HRH3 (0.54) NCF1HRH3HTTSMN1; SMN2NOS1
Ammonia Solution, Strong SCHEMBL548075 0.77 HRH3 (0.58) NCF1HRH3HTTSMN1; SMN2NOS1
SCHEMBL14320176 0.77 HRH3 (0.50) NCF1HRH3HTTSMN1; SMN2NOS1
SCHEMBL15677807 0.76 HIF1A (0.64) HRH3HTTSMN1; SMN2NOS1NOS3
SCHEMBL16054673 0.75 HRH3 (0.54) NCF1HRH3HTTSMN1; SMN2NOS1
SCHEMBL4974297 0.75 HTT (0.55) NCF1HRH3HTTSMN1; SMN2NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022073469-A1 COMPOUNDS AND METHODS OF TREATING CANCERS CULLGEN (SHANGHAI) , INC. (CN) 2022-04-14 WO disclosed